ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 164 filers reported holding ADMA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $175,495 | +310.1% | 49,021 | +322.7% | 0.03% | +275.0% |
| Q2 2023 | $42,797 | -87.8% | 11,598 | -89.1% | 0.01% | -89.2% |
| Q1 2023 | $350,847 | +751.1% | 105,996 | +897.7% | 0.07% | +722.2% |
| Q4 2022 | $41,221 | -20.7% | 10,624 | -50.2% | 0.01% | -30.8% |
| Q3 2022 | $52,000 | +160.0% | 21,328 | +20.4% | 0.01% | +85.7% |
| Q3 2021 | $20,000 | -50.0% | 17,709 | -28.8% | 0.01% | -46.2% |
| Q2 2021 | $40,000 | – | 24,881 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
| Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
| Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
| AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
| Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
| Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
| Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
| TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
| EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |